Latest Breaking News On - Hedge funds weigh in on assembly biosciences - Page 1 : comparemela.com

Assembly Biosciences, Inc (NASDAQ:ASMB) Insider Nicole S White Sells 1,255 Shares of Stock

Assembly Biosciences, Inc (NASDAQ:ASMB) Insider Nicole S White Sells 1,255 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNicoles whiteExchange commissionNews ratings for assembly biosciences dailyQuarter for assembly biosciencesMarquette asset managementAssembly biosciencesAssembly biosciences price performanceHedge funds weigh in on assembly biosciencesAssembly biosciences company profileSecurities exchange commissionAssembly biosciences incGet free reportAsset managementFree reportAssembly biosciences daily

Assembly Biosciences, Inc (NASDAQ:ASMB) CEO Jason A Okazaki Sells 1,569 Shares

Assembly Biosciences, Inc (NASDAQ:ASMB) CEO Jason A Okazaki Sells 1,569 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJasona okazakiAcuitas investmentsNews ratings for assembly biosciences dailyAssembly biosciencesSecurities exchange commissionQuarter for assembly biosciencesAssembly biosciences stockHedge funds weigh in on assembly biosciencesAssembly biosciences incAssembly biosciences company profileGet free reportExchange commissionFree reportAssembly biosciences daily

Assembly Biosciences (NASDAQ:ASMB) Upgraded by StockNews com to Hold

StockNews.com upgraded shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright reaffirmed a neutral rating on shares of Assembly Biosciences in a research report on Monday, April 1st. Check Out Our Latest Stock Report on Assembly Biosciences Assembly […]

United statesAlexander schornsteinNews ratings for assembly biosciences dailyTower research capitalJpmorgan chase coHedge funds weigh in on assembly biosciencesSecurities exchange commissionAssembly biosciences company profileAssembly biosciencesAssembly biosciences incAssembly biosciences stockFree reportExchange commissionStreet groupResearch capitalTwo sigma investments

Assembly Biosciences (ASMB) Neutral Rating Reiterated at HC Wainwright

HC Wainwright reissued their neutral rating on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Assembly Biosciences’ Q1 2024 earnings at ($2.74) EPS, Q2 2024 earnings at ($2.96) EPS, Q3 2024 earnings at ($3.29) EPS, Q4 2024 earnings […]

United statesAlexander schornsteinAssembly bioscienceInsider activity at assembly biosciencesAcuitas investmentsMarquette asset managementHedge funds weigh in on assembly biosciencesVanguard group incAssembly biosciences company profileAssembly biosciences incGeode capital managementAssembly biosciences stockNorthern trust corpSecurities exchange commissionAssembly biosciencesNews ratings for assembly biosciences daily

Short Interest in Assembly Biosciences, Inc (NASDAQ:ASMB) Declines By 22 1%

Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 353,300 shares, a drop of 22.1% from the January 15th total of 453,600 shares. Based on an average daily trading volume, of 526,300 shares, the days-to-cover ratio is presently […]

United statesAlexander schornsteinNews ratings for assembly biosciences dailyRenaissance technologiesHedge funds weigh in on assembly biosciencesAssembly biosciences stock performanceAcuitas investmentsAssembly biosciences incGoldman sachs group incAssembly biosciencesGeode capital managementGet free reportSachs groupStreet groupCapital managementAssembly biosciences daily